Sonosite ranked fourth on 2003 "Fast Technology 50" list in Washington StateBOTHELL, WA, September 25, 2003 - Sonosite, Inc. (Nasdaq: SONO), a leading point-of-care ultrasound company, today announced that the company has been named a 2003 "Fast Technology 50" company in Washington State by the accounting firm of Deloitte & Touche. The company also announced the hiring of three new executives to support Sonosite's worldwide growth. These announcements were made in conjunction with President and CEO Kevin Goodwin's presentation at the UBS Global Life Sciences Conference in New York City."Sonosite is recognized worldwide for its leadership in point-of-care ultrasound applications, with more than 12,000 systems in use in hospitals, doctors" offices and other healthcare environments, such as in the military," Goodwin said. "Our exponential growth can be attributed to the tremendous market need for and interest in mobile, hand-carried ultrasound systems. We anticipate sustaining growth by removing barriers to the use of ultrasound across the healthcare continuum and putting in place key people with the experience to drive our business forward."… [Read more]
Presentations to be WebcastBOTHELL, WA, November 7, 2003 - Sonosite, Inc. (Nasdaq: SONO) a leader in the point-of-care ultrasound market, announced today that Kevin Goodwin, president and CEO, will present at the RBC Dain Rauscher Premier Client Investor Conference in Seattle and the Robins Group Small Cap Round-up Conference in Portland, Oregon in November.The RBC Dain Rauscher Conference will be held on November 11, 2003 at the Seattle Sheraton Hotel and Towers. Mr. Goodwin will present at 8:00 am PST. Interested investors can listen to the presentation live via webcast at http://www.RBCDain.com. The presentation will be archived on the site until December 11, 2003.The Robins Group Small Cap Round-up Conference will be held on November 12, 2003 at The Embassy Suites Hotel (Southwest Pine Street) in Portland, Oregon. Mr. Goodwin will present at 8:30 am PST. Interested investors can listen to the presentation live via webcast at http://www.veracast.com/webcasts/robins/small-cap-roundup03/33103169.cfm. The presentation will be archived on the site until December 12, 2003.… [Read more]
Vascular imaging and connectivity highlighted; expanded features available mid-December… [Read more]
Live Presentation Available Via Audio-Webcast
BOTHELL, WA, April 29, 2003 - Sonosite, Inc. (Nasdaq: SONO), the leader in point-of-care ultrasound, today announced that Kevin M. Goodwin, president and CEO of Sonosite, will present at the Deutsche Bank Health Care Conference at 9 a.m. (EDT) on Tuesday, May 6, 2003, at the Marriott Baltimore Waterfront Hotel in Baltimore, MD. Interested investors can listen to a live audio-webcast at http://www.visualwebcaster.com/event.asp?id=14061. A replay of the audiocast will be archived on the website for 90 days.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.… [Read more]
Third Quarter Per Share Loss Reduced to $0.01 from loss of $0.17 in 2002 BOTHELL, WA, October 30, 2003 - Sonosite, Inc. (Nasdaq: SONO), a leading point-of-care ultrasound company, today announced increased revenue and gross margins as well as a reduced loss for the third quarter and nine months ended September 30, 2003.As the Company previously projected in a news release issued on October 13, 2003, Sonosite reported third quarter revenue of $20.2 million, an increase of 10 percent, compared with $18.5 million for the third quarter of 2002. For the nine months of 2003, revenue grew 20 percent to $57.5 million compared with $47.9 million for the same period in the prior year.The Company reported a net loss of $0.2 million, or $0.01 per share, versus a net loss of $2.4 million, or $0.17 per share, for the third quarter of 2002. Earnings per share results were modestly better than projected due to a favorable foreign exchange rate gain. For the nine months, the Company's loss narrowed to $4.0 million, or $0.28 per share, versus a loss of $8.6 million, or $0.68 per share for the same period a year earlier. As of September 30, 2003, cash, cash equivalents and investments totaled $61.6 million.… [Read more]
BOTHELL, WASH., January 21, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the Piper Jaffray Health Care Conference at The Pierre in New York on Wednesday, January 26, 2005 at 10:00 am (EST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days.About Sonosite… [Read more]
TITAN Cardiac Features Bring Full Echo Capabilities to Point Of Care
ACC Sessions Address Growing Importance of IMT
ORLANDO - March 4, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the world leader in hand carried ultrasound, today announced that the Company will highlight the cardiac capabilities of its high performance TITAN ultrasound system, including the new SonoCalc„¢ IMT (Intima Media Thickness) software for assessment of cardiovascular risk, at the 54th Annual Scientific Session of the American College of Cardiology (ACC) being held from March 6 - 9, 2005.
"For the first time, IMT capability is now offered on a hand-carried ultrasound system, making it easily affordable and accessible in the physician's office," said Kevin M. Goodwin, Sonosite President and CEO. "IMT has long been recognized by the cardiac research community as an effective indicator of heart disease, particularly in people who are otherwise asymptomatic. The numerous scientific sessions on IMT at this ACC indicate a growing interest in moving this technique from research to everyday clinical diagnostic use."
Sonosite is offering a demonstration of its SonoCalc IMT software in booth #3563 at the ACC Scientific Sessions.
Sonosite is also showcasing the recent expansion of capabilities on its high performance TITAN system for the shared service and dedicated echocardiography markets.… [Read more]
BOTHELL, WA - May 24, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that it will present at the Pacific Growth Equities Life Sciences Growth Conference at the InterContinental Mark Hopkins Hotel in San Francisco, Tuesday, June 7th, 2005 at 09:00 am (PDT). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://ir.sonosite.com. An archived replay of the presentation will also be available approximately an hour following the live presentation and will be available for 30 days.About Sonosite… [Read more]
Company Reports EPS of $0.05Conference Call Today at 1:30 pm PT/4:30 ETBOTHELL, WA - April 28, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today reported strong financial results for the first quarter ended March 31, 2005.Worldwide revenue in the first quarter of 2005 grew 44% to $34.0 million compared with $23.5 million in the first quarter of 2004. The company achieved pre-tax income of $1.4 million in the first quarter of 2005 and reported net income in the first quarter of $725,000, or $0.05 per diluted share, compared with a loss of $1.4 million, or $0.10 per share, a year ago."The year is off to an exceptionally strong start," said Kevin M. Goodwin, Sonosite President and CEO. "The quarter's outstanding results were due to excellent execution in both US and International markets. During the second quarter we will be focused on the worldwide launch of the MicroMaxx„¢ system, our third generation of hand-carried ultrasound technology. We will be hosting events in the US, Canada, Europe and Asia to give physicians and sonographers a first hand look at this powerful yet lightweight system and we plan to begin customer shipments in mid-June."… [Read more]
Transaction combines high-quality imaging technologies and pioneering point-of-care expertise to drive next generation medical imaging solutions
Tokyo, Japan / Bothell, WA, U.S. – December 15, 2011 – FUJIFILM Holdings Corporation (TSE: 4901, hereinafter: Fujifilm), a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today that it has entered into a definitive agreement with Sonosite, Inc. (NASDAQ: SONO, hereinafter: Sonosite), a pioneer and leader in bedside and point-of-care ultrasound technology, pursuant to which Fujifilm will acquire Sonosite for approximately $995 million (which includes amounts payable in connection with its convertible debt). The transaction was unanimously approved by the Boards of Directors of both companies.… [Read more]
BOTHELL, WA - December 20, 2005 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, said today that an independently conducted, random survey of MicroMaxx system customers showed that nearly all customers (97%) surveyed are highly satisfied overall with their MicroMaxx system and would recommend the system to their colleagues. Image quality, ease of use and system durability were key reasons for the high satisfaction rating, with 72% saying that the image quality of the MicroMaxx system is better than other ultrasound products they have used.… [Read more]
BOTHELL, WA - April 30, 2007 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today reported financial results for the first quarter ended March 31, 2007.
Worldwide revenue in the first quarter of 2007 grew 16% to $42.8 million compared with $36.9 million in the first quarter of 2006. For the first quarter of 2007, Sonosite reported a net loss of $563,000 or $0.03 per share, compared with a net loss of $363,000 or $0.02 per share in the prior year quarter.
"With a good start to the year, we are on track to achieve our revenue growth objectives for 2007," said Kevin M. Goodwin, Sonosite President and CEO. "Our international business which was up 25% compared to last year, showed positive, broad-based trends throughout our major markets and is benefiting from the investments we made in 2006 to increase sales capacity in several countries. Overall US revenue was up 7% for the quarter with much higher growth rates in our hospital point-of-care markets and enterprise business. The total growth rate was offset by sales in the private office channel, which we continue to develop. We are taking a number of steps to increase the effectiveness of this channel and expect to see our US business strengthen as we move through the year."
… [Read more]
BOTHELL, WA - December 20, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, Sonosite’s President and CEO, will present at the 29th Annual JP Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 10-13, 2011.
The session will be webcast live on Wednesday, January 12, 2011 at 9:30 am Pacific Time. An audio replay will be available for 30 days following and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
US Revenue Up 17%
International Revenue Up 7%
VisualSonics Revenue Up 30%
Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern
BOTHELL, WA - October 21, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2010.
REVENUE
Revenue increased 28% in the third quarter to $68.5 million and increased 18% for the nine months of 2010 to $186.1 million, as compared to the prior year.
Revenue included $8.7 million for the third quarter and nine months from the recently acquired VisualSonics (VSI).
Excluding VSI, revenue in the third quarter was $59.8 million, an increase of 12% compared to the third quarter of 2009, and $177.4 million, an increase of 12% for the nine months just ended.
… [Read more]
Revolutionary portable technology provides dynamic assessment of soft tissue and bone injuries
BOTHELL, WA - October 21, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the National Basketball Association (NBA), announced today a multiyear agreement to introduce Sonosite's ultrasound technology to the NBA's medical and athletic training professionals.
As part of the agreement, Sonosite will be the preferred provider of ultrasound products to the NBA and the NBA Development League (NBA D-League). This relationship will educate the NBA and NBA D-League's team physicians and athletic trainers about Sonosite's unique diagnostic ultrasound tools that are highly portable and can assist in efficiently diagnosing, treating, and monitoring the rehabilitation of professional athletes.
… [Read more]
BOTHELL, WA - October 14, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that its latest breakthrough in ultrasound imaging, Advanced Needle Visualization, will be featured at the American Society of Anesthesiologists 2010 Annual Meeting. This technology was first introduced in July 2010 and is a proprietary imaging algorithm that intensifies the brightness of the needle, making it clearly visible during a steep angle nerve block approach for deep targets, conditions under which the needle has previously been very difficult to image. The conference is being held in San Diego, California at the San Diego Convention Center, October 16-18, 2010
As a solution for the "lost needle phenomenon," which has been a well-known limitation in ultrasound needle imaging, anesthesiologists worldwide have quickly responded to Advanced Needle Visualization as a key tool for saving time, and improving patient safety. The algorithm enables physicians to increase confidence through visualization of the needle, which may result in less procedure time while maintaining fully-diagnostic image quality from near to far field, preserving anatomical detail.
… [Read more]
BOTHELL, WA - October 7, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it will report the company's third quarter financial results on Thursday, October 21, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on that day. The call will be broadcast live and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts.
A replay of the audio webcast will be available beginning October 21, 2010 at 5:30 p.m. PT and can be accessed until November 4, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7304277 is required to access the replay. Additionally, the call will be archived on Sonosite’s website.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
BOTHELL, WA - September 2, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, Sonosite's President and CEO, will present at the Stifel Nicolaus Healthcare Conference being held at the Four Seasons Hotel in Boston from September 15-17, 2010.
The session will be webcast live on Wednesday, September 15 at 11:30 am, Eastern Time. An audio replay will be available for 30 days following and can be accessed via Sonosite's website at www.sonosite.com/investorinformation/webcasts.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
First Generation Product Provides Unique Tracking and Guidance Technology for PICC Line Procedures
BOTHELL, WA - August 26, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it received FDA clearance for its innovative LumenVu® Catheter Guidance System. Designed to aid in the placement of peripherally inserted central catheters (PICC), the proprietary LumenVu System combines near-infrared technology with a revolutionary fiber optic stylet, which replaces a traditional guide wire, to allow visualization and real-time tracking of a catheter tip as it advances through a vein.
"Receiving FDA clearance is an important milestone in the strategic development and global commercialization of the LumenVu System and it reinforces our dedication to providing patients with improved safety and health," said Kevin M. Goodwin, Sonosite's President and CEO.
"We envision this technology ultimately advancing beyond PICC line placements and potentially into a broader range of clinical applications. This clearance also represents a significant step towards the development of a fully integrated line placement imaging solution, which will include ultrasound visualization."… [Read more]